Saving lives: Long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy
Summary Prospective randomised trials have demonstrated convincingly the benefits of drug treatment of hypertension. Treatment with conventional antihypertensive agents reduces the incidence of cardiovascular events by about that which would be expected from epidemiological data for the achieved dif...
Main Author: | Gordon T McInnes |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2000-06-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.3317/JRAAS.2000.048 |
Similar Items
-
Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy
by: Gordon T McInnes
Published: (2000-06-01) -
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
by: Neil Poulter, et al.
Published: (2006-06-01) -
Long-term use of angiotensin receptor blockers and the risk of cancer.
by: Laurent Azoulay, et al.
Published: (2012-01-01) -
The Benefits of Angiotensin Receptor Blockers in Patients with Chronic Heart Failure and Multiple Co-morbidities
by: Erland Erdmann
Published: (2005-06-01) -
Podocyte-Related Mechanisms Underlying Survival Benefit of Long-Term Angiotensin Receptor Blocker
by: Xuejing Zhu, et al.
Published: (2022-05-01)